TGFB1 and hepatocellular carcinoma: Thus, the presented data in the context of the current state of the art further indicate that the TGF-β signaling pathway has strong and critical impact on hepatocyte fate decisions that are directly related to liver diseases, including ASH, NASH, and HCC.